Welcome to the Teva IMPACT-TD Registry website
We need your help to uncover how tardive dyskinesia (TD) develops over time and its impact on individuals
TD
What is TD?
TD is a potential long-term side effect of antipsychotic medications that causes the body to make sudden, uncontrollable movements, usually in the face1
In 2016, TD was estimated to affect 573,000 people in the US2
In other words, this represents 9% of people taking antipsychotic medication*2
*Data based on a disease burden model
Impact
TD can have a devastating impact on the way a person's body functions, their mental
well-being and how they interact with other people
3 out of 4 people with TD say that it severely impacts them physically, psychologically and socially3
However, the extent of the impact and the progression of disease is poorly understood3,4
We are committed to changing this, and we need your help
Explore this website to learn more about the Teva IMPACT-TD Registry or e-mail us on impactTD@iqvia.com for further information.
Please select from the below to learn more
References
- Lerner PP, et al. Psychiatry Clin Neurosci 2015;69:321–34.
- Dhir A, et al. Presented at the American Academy of Neurology Annual Meeting. April 22–28, 2017; Boston, MA USA. Poster 2.018.
- Jain R, et al. Presented at Psych Congress Annual Meeting; Oct 29–Nov 1, 2021; San Antonio, TX USA.
- Carbon M, et al. J Clin Psychiatry 2017;78:e264–e278.